The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-center experience with intimal sarcoma, an ultra-orphan, commonly fatal mesenchymal malignancy.
 
Julie Van Dievel
Travel, Accommodations, Expenses - Teva
 
Raf Sciot
No Relationships to Disclose
 
Marion Delcroix
No Relationships to Disclose
 
Raf Vandeweyer
Employment - Janssen
Honoraria - Janssen
Consulting or Advisory Role - Janssen
 
Maria Debiec-Rychter
No Relationships to Disclose
 
Barbara Dewaele
No Relationships to Disclose
 
Jasmien Cornillie
No Relationships to Disclose
 
Thomas Van Cann
Travel, Accommodations, Expenses - PharmaMar
 
Bart Meyns
No Relationships to Disclose
 
Patrick Schöffski
Honoraria - Daiichi Sankyo; Eisai; Lilly; Medpace; Novartis; Swedish Orphan Biovitrum
Consulting or Advisory Role - 6th Element Capital (Inst); Adaptimmune (Inst); Amcure (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); BMS Brazil (Inst); Boehringer Ingelheim (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Epizyme (Inst); Genzyme (Inst); Ipsen (Inst); Lilly (Inst); Loxo (Inst); Medpace (Inst); Nektar (Inst); Novartis (Inst); Philogen (Inst); Pique (Inst); Plexxikon (Inst)
Speakers' Bureau - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Swedish Orphan Biovitrum
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); CoBioRes NV (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - 6th Element Capital; Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Medicines; BMS Brazil; Boehringer Ingelheim; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Genzyme; GlaxoSmithKline; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; PharmaMar; Philogen; Piqur; Plexxikon; Swedish Orphan Biovitrum